MORGAN STANLEY - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 18 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2022$558
-44.2%
1,500
-0.1%
0.00%
Q3 2022$1,0000.0%1,502
+0.1%
0.00%
Q2 2022$1,0000.0%1,500
-0.5%
0.00%
Q1 2022$1,000
-50.0%
1,507
+0.4%
0.00%
Q4 2021$2,000
-33.3%
1,501
+0.1%
0.00%
Q3 2021$3,0000.0%1,5000.0%0.00%
Q2 2021$3,000
-25.0%
1,5000.0%0.00%
Q1 2021$4,0000.0%1,5000.0%0.00%
Q4 2020$4,0001,500
+1644.2%
0.00%
Q1 2020$0860.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
VANGUARD GROUP INC 154,536$57,4870.00%
UBS Group AG 23,029$8,5210.00%
TWO SIGMA INVESTMENTS, LP 22,398$8,3320.00%
Cetera Investment Advisers 75,000$27,9000.00%
WELLS FARGO & COMPANY/MN 93$350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 106,917$390.00%
MORGAN STANLEY 1,500$5580.00%
BlackRock Inc. 19$70.00%
TWO SIGMA SECURITIES, LLC 19,707$7,3310.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders